STOCK TITAN

Daniel O'Day plans 10,000-share sale in GILD (NASDAQ: GILD)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Daniel O'Day filed a notice to sell 10,000 common shares through Morgan Stanley Smith Barney LLC on or about 01/28/2026, with an aggregate market value of $1,398,911.00 on NASDAQ.

The 10,000 shares were acquired as performance shares from the issuer on 01/31/2024. Over the past three months, O'Day has already sold 10,000 shares on each of 10/28/2025, 11/28/2025, and 12/29/2025, plus 115,640 shares on 01/23/2026, for gross proceeds ranging from about $1.19 million to $15.61 million per transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Daniel O'Day’s latest Form 144 filing for GILD indicate?

The filing indicates Daniel O'Day plans to sell 10,000 common shares on or about 01/28/2026. The proposed sale, routed through Morgan Stanley Smith Barney LLC on NASDAQ, reflects an aggregate market value of $1,398,911.00 based on the filing data.

How many GILD shares has Daniel O'Day sold in the last three months?

Over the last three months, Daniel O'Day has sold 145,640 common shares. These include three sales of 10,000 shares each on 10/28/2025, 11/28/2025, and 12/29/2025, plus a larger sale of 115,640 shares on 01/23/2026.

What proceeds did Daniel O'Day receive from recent GILD share sales?

Recent sales generated substantial proceeds. The three 10,000-share sales produced $1,193,926.00, $1,265,444.00, and $1,248,272.00. The larger 115,640-share transaction on 01/23/2026 brought in $15,611,400.00 in gross proceeds, according to the filing.

How and when did Daniel O'Day acquire the 10,000 GILD shares to be sold?

The 10,000 shares proposed for sale were acquired as performance shares on 01/31/2024 directly from the issuer. The filing lists the acquisition as a performance-based award, with payment described as “Not Applicable” rather than a cash purchase.

Which broker and exchange are involved in Daniel O'Day’s planned GILD share sale?

The planned 10,000-share sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing specifies that the transaction is to occur on the NASDAQ exchange, aligning the sale with standard market trading for the issuer’s common stock.

How many issuer shares are outstanding in Daniel O'Day’s Form 144 for GILD?

The filing notes that there are 1,240,679,623 common shares outstanding. This figure provides context for the scale of Daniel O'Day’s planned and recent sales relative to the issuer’s total equity base as reported in the notice.
Gilead Sciences Inc

NASDAQ:GILD

GILD Rankings

GILD Latest News

GILD Latest SEC Filings

GILD Stock Data

173.14B
1.24B
0.1%
90.75%
1.42%
Drug Manufacturers - General
Biological Products, (no Disgnostic Substances)
Link
United States
FOSTER CITY